Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$0.49 - $1.16 $20,531 - $48,605
-41,901 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.87 - $2.26 $19,504 - $23,571
10,430 Added 33.14%
41,901 $79,000
Q1 2019

May 15, 2019

BUY
$1.9 - $3.9 $59,794 - $122,736
31,471 New
31,471 $85,000

Others Institutions Holding CHEK

# of Institutions
1
Shares Held
9.1K
Call Options Held
0
Put Options Held
0

About Check-Cap Ltd


  • Ticker CHEK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 116,412,000
  • Market Cap $105M
  • Description
  • Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for d...
More about CHEK
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.